Overview

Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin Hydrochloride

Status:
Not yet recruiting
Trial end date:
2021-07-05
Target enrollment:
Participant gender:
Summary
The DDI study had been designed to investigate the effect of SHR3680 on the pharmacokinetics of digoxin, Rosuvastatin calcium and metformin hydrochloride
Phase:
Phase 1
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Treatments:
Calcium
Digoxin
Metformin
Rosuvastatin Calcium